Pfizer Publications Clause Samples
The "Pfizer Publications" clause defines the rights and procedures related to the publication of research results or data generated under an agreement involving Pfizer. Typically, this clause outlines how and when Pfizer or its collaborators may publish findings, often requiring prior review or approval to protect confidential information or intellectual property. Its core function is to balance the dissemination of scientific knowledge with the protection of proprietary interests, ensuring that sensitive information is not disclosed prematurely while still allowing for academic or scientific publication.
Pfizer Publications. During the Research Term, Pfizer will submit to BioNTech for review and approval any proposed academic, scientific and medical publication or public presentation which contains Confidential Information of BioNTech or its Representatives. Such review and approval will be conducted for the purposes of determining whether any portion of the proposed publication or presentation containing Confidential Information of BioNTech or its Representatives should be modified or deleted. Written copies of such proposed publication or presentation required to be submitted hereunder will be submitted to BioNTech no later than [***] days before submission for publication or presentation (the “BioNTech Review Period”). BioNTech will provide its comments with respect to such publications and presentations within [***] days of its receipt of such written copy. The BioNTech Review Period may be extended for an additional [***] days in the event BioNTech can, within ten days of receipt of the written copy, demonstrate reasonable need for such extension including for the preparation and filing of patent applications. Pfizer will comply with standard academic practice regarding authorship of scientific publications and recognition of contribution of other parties in any publication governed by this Section 8.5.3, including International Committee of Medical Journal Editors standards regarding authorship and contributions.
